China Shenghuo Pharmaceutical Income Statement
View: Annual
This data is provided as per license from EDGAR Online
| Dec 07 | Dec 06 | Dec 05 | |
|---|---|---|---|
| Revenue | 20.0 | 20.0 | 0.0 |
| Cost of Goods Sold | 5.0 | 6.4 | -- |
| Gross Profit | 14.9 | 13.6 | -- |
| Gross Profit Margin | 74.8% | 67.9% | 0.0% |
| SG&A Expense | 11.4 | 8.5 | 0.0 |
| Depreciation & Amortization | 0.7 | 0.7 | -- |
| Operating Income | 2.9 | 4.4 | (0.0) |
| Operating Margin | 14.5% | 21.9% | -- |
| Nonoperating Income | 0.4 | 0.1 | -- |
| Nonoperating Expenses | 0.9 | 0.8 | -- |
| Income Before Taxes | 2.3 | 3.7 | (0.0) |
| Income Taxes | (2.0) | 0.4 | -- |
| Net Income After Taxes | 4.3 | 3.3 | (0.0) |
| Continuing Operations | 4.0 | 3.0 | (0.0) |
| Discontinued Operations | -- | -- | -- |
| Total Operations | 4.0 | 3.0 | (0.0) |
| Total Net Income | 4.0 | 3.0 | (0.0) |
| Net Profit Margin | 20.1% | 15.0% | -- |
| Diluted EPS from Total Net Income ($) | 0.21 | 0.17 | -- |
| Dividends per Share | -- | -- | -- |
This data is provided as per license from EDGAR Online
